Sungalee S, Liu Y, Lambuta R, Katanayeva N, Donaldson Collier M, Tavernari D
Nat Genet. 2021; 53(5):650-662.
PMID: 33972799
DOI: 10.1038/s41588-021-00842-x.
Keyvani V, Farshchian M, Esmaeili S, Yari H, Moghbeli M, Nezhad S
J Ovarian Res. 2019; 12(1):120.
PMID: 31810474
PMC: 6896744.
DOI: 10.1186/s13048-019-0588-z.
Sharma A, Boise L, Shanmugam M
Cancers (Basel). 2019; 11(8).
PMID: 31405035
PMC: 6721599.
DOI: 10.3390/cancers11081144.
Hardwick J
mBio. 2018; 9(4).
PMID: 30065087
PMC: 6069115.
DOI: 10.1128/mBio.00948-18.
Perini G, Ribeiro G, Pinto Neto J, Campos L, Hamerschlak N
J Hematol Oncol. 2018; 11(1):65.
PMID: 29747654
PMC: 5946445.
DOI: 10.1186/s13045-018-0608-2.
Targeting BCL2-Proteins for the Treatment of Solid Tumours.
Vogler M
Adv Med. 2015; 2014:943648.
PMID: 26556430
PMC: 4590949.
DOI: 10.1155/2014/943648.
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.
Reagan P, Friedberg J
Curr Treat Options Oncol. 2015; 16(7):32.
PMID: 26031546
DOI: 10.1007/s11864-015-0351-7.
Follicular lymphoma: too many reminders for a memory B cell.
Swaminathan S, Muschen M
J Clin Invest. 2014; 124(12):5095-8.
PMID: 25384212
PMC: 4348960.
DOI: 10.1172/JCI79189.
Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking.
Hirt C, Weitmann K, Schuler F, Kiefer T, Rabkin C, Hoffmann W
Leuk Lymphoma. 2013; 54(12):2678-84.
PMID: 23527525
PMC: 4444076.
DOI: 10.3109/10428194.2013.788177.
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype.
Kunkalla K, Liu Y, Qu C, Leventaki V, Agarwal N, Singh R
Ann Hematol. 2013; 92(6):777-87.
PMID: 23370596
PMC: 3648611.
DOI: 10.1007/s00277-013-1684-6.
Mechanisms of chemoresistance in cancer stem cells.
Abdullah L, Chow E
Clin Transl Med. 2013; 2(1):3.
PMID: 23369605
PMC: 3565873.
DOI: 10.1186/2001-1326-2-3.
Chromosomal translocations among the healthy human population: implications in oncogenesis.
Nambiar M, Raghavan S
Cell Mol Life Sci. 2012; 70(8):1381-92.
PMID: 22948164
PMC: 11113647.
DOI: 10.1007/s00018-012-1135-x.
A case of an abdominal mass: follicular lymphoma.
Walker T, Lopez G
Perm J. 2012; 15(4):61-4.
PMID: 22319418
PMC: 3267563.
DOI: 10.7812/tpp/10-102.
Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence.
Fischer M, Moreno-Miralles I, Hunt A, Chyla B, Hiebert S
EMBO J. 2012; 31(6):1494-505.
PMID: 22266796
PMC: 3321173.
DOI: 10.1038/emboj.2011.500.
The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
Xiang H, Noonan E, Wang J, Duan H, Ma L, Michie S
Leukemia. 2011; 25(9):1484-93.
PMID: 21606958
PMC: 3162065.
DOI: 10.1038/leu.2011.115.
Genomic profiles in B cell lymphoma.
Seto M
Int J Hematol. 2010; 92(2):238-45.
PMID: 20799004
DOI: 10.1007/s12185-010-0662-1.
The BCL-2 5' untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression.
Shahid R, Bugaut A, Balasubramanian S
Biochemistry. 2010; 49(38):8300-6.
PMID: 20726580
PMC: 3038430.
DOI: 10.1021/bi100957h.
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.
Lapucci A, Lulli M, Amedei A, Papucci L, Witort E, Di Gesualdo F
FASEB J. 2010; 24(6):1852-65.
PMID: 20103721
PMC: 2874474.
DOI: 10.1096/fj.09-140459.
Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.
Nemec K, Khaled A
Yonsei Med J. 2008; 49(5):689-97.
PMID: 18972587
PMC: 2615374.
DOI: 10.3349/ymj.2008.49.5.689.
Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
Duan H, Xiang H, Ma L, Boxer L
Oncogene. 2008; 27(53):6720-8.
PMID: 18695675
PMC: 2613909.
DOI: 10.1038/onc.2008.286.